Cargando…
A Short Half-Life α(IIb)β(3) Antagonist ANTP266 Reduces Thrombus Formation
Integrin α(IIb)β(3) plays a pivotal role in platelet aggregation. Three α(IIb)β(3) antagonists have been approved by the Food and Drug Administration (FDA) for the treatment of cardiovascular diseases. Unfortunately, all of these three drugs can cause the side effect of severe bleeding. Therefore, d...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121621/ https://www.ncbi.nlm.nih.gov/pubmed/30082659 http://dx.doi.org/10.3390/ijms19082306 |